Safety and efficacy data supporting US FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management

Wilson M. Edward; Trivedi Rupal H.; Plager David A.

首页> 外文期刊>Journal of cataract and refractive surgery >Safety and efficacy data supporting US FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management

【24h】

Safety and efficacy data supporting US FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management

机译：支持美国FDA的安全性和功效数据批准肠道邻藻肾上腺素和酮洛尔克的小儿白内障手术的1.0％/ 0.3％：临床安全和瞳孔和疼痛管理

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To assess the safety of phenylephrine and ketorolac (PE/K) 1.0%/0.3% compared with phenylephrine (PE) 1.0% in children aged 0 to 3 years undergoing cataract surgery. The effect of PE/K to PE on intraoperative pupil diameter and postoperative pain were also compared.

机译：目的：评估苯妥和Ketorolac（PE / K）的安全性与苯妥（PE / k）1.0％/ 0.3％，与在经历白内障手术的儿童中的苯妥林（PE）1.0％。比较PE / K对术中瞳孔直径和术后疼痛的影响。

著录项

来源
《Journal of cataract and refractive surgery》 |2020年第6期|共6页
作者
Wilson M. Edward; Trivedi Rupal H.; Plager David A.;
展开▼
作者单位

Med Univ South Carolina Storm Eye Inst 167 Ashley Ave Charleston SC 29425 USA;

Med Univ South Carolina Storm Eye Inst 167 Ashley Ave Charleston SC 29425 USA;

Indiana Univ Indianapolis IN 46204 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
专利

1. Safety and efficacy data supporting US FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management [J] . Wilson M. Edward, Trivedi Rupal H., Plager David A. Journal of cataract and refractive surgery . 2020,第6期

机译：支持美国FDA的安全性和功效数据批准肠道邻藻肾上腺素和酮洛尔克的小儿白内障手术的1.0％/ 0.3％：临床安全和瞳孔和疼痛管理
2. Effect Of Intracameral Phenylephrine And Ketorolac 1.0%/0.3% On Intraoperative Pain And Opioid Use During Cataract Surgery [J] . Eric D Donnenfeld, Ryan D Shojaei Clinical ophthalmology . 2019,第4期

机译：在白内障手术期间，肠内苯妥和酮卟啉和Ketorolac 1.0％/ 0.3％的影响
3. Visual outcomes, efficacy, and surgical complications associated with intracameral phenylephrine 1.0%/ketorolac 0.3% administered during cataract surgery [J] . Eric D Rosenberg, Alanna S Nattis, David Alevi, Clinical ophthalmology . 2017,第10期

机译：白内障手术期间与前房内去氧肾上腺素1.0％/酮咯酸0.3％相关的视觉效果，疗效和手术并发症
4. Value of Condition Monitoring Data in Safety Management Decision Support [C] . Simon Jeeves Abu Dhabi International Petroleum Exhibition Conference . 2018

机译：安全管理决策支持中条件监测数据的价值
5. Effect Of Intracameral Phenylephrine And Ketorolac 1.0/0.3 On Intraoperative Pain And Opioid Use During Cataract Surgery [O] . Eric D Donnenfeld, Ryan D Shojaei 2019

机译：白内障手术中小儿苯去氧肾上腺素和酮咯酸1.0％/ 0.3％对术中疼痛和阿片类药物使用的影响
6. OMS302 (phenylephrine and ketorolac injection) 1/0.3 to maintain intraoperative pupil size and to prevent postoperative ocular pain in cataract surgery with intraocular lens replacement [O] . Robert H Osher, Iqbal Ike K Ahmed, Gregory A Demopulos 2015

机译：OMS302（苯妥和Ketorolac注射），保持术中瞳孔尺寸1％/ 0.3％，以防止具有眼内透镜的白内障手术中的术后眼部疼痛

Safety and efficacy data supporting US FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management

摘要

著录项

相似文献

相关主题

期刊订阅